Division of Epidemiology, School of Public Health, University of California, Berkeley, CA (XX Abrams).
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA (XX Leonard, XX Lyell, and Dr Carmichael).
Am J Obstet Gynecol MFM. 2022 May;4(3):100596. doi: 10.1016/j.ajogmf.2022.100596. Epub 2022 Feb 15.
Prepregnancy body mass index and gestational weight gain have been linked with severe maternal morbidity, suggesting that weight change between pregnancies may also play a role, as it does for neonatal outcomes.
This study assessed the association of changes in prepregnancy body mass index between 2 consecutive singleton pregnancies with the outcomes of severe maternal morbidity, stillbirth, and small- and large-for-gestational-age infants in the subsequent pregnancy.
This observational study was based on birth records from 1,111,032 consecutive pregnancies linked to hospital discharge records in California (2007-2017). Interpregnancy body mass index change between the beginning of an index pregnancy and the beginning of the subsequent pregnancy was calculated from self-reported weight and height. Severe maternal morbidity was defined based on the Centers for Disease Control and Prevention index, including and excluding transfusion-only cases. We used multivariable log-binomial regression models to estimate adjusted risks, overall and stratified by prepregnancy body mass index at index birth.
Substantial interpregnancy body mass index gain (≥4 kg/m) was associated with severe maternal morbidity in crude but not adjusted analyses. Substantial interpregnancy body mass index loss (>2 kg/m) was associated with increased risk of severe maternal morbidity (adjusted relative risk, 1.13; 95% confidence interval (1.07-1.19), and both substantial loss (adjusted relative risk, 1.11 [1.02-1.19]) and gain (≥4 kg/m; adjusted relative risk, 1.09 [1.02-1.17]) were associated with nontransfusion severe maternal morbidity. Substantial loss (adjusted relative risk, 1.17 [1.05-1.31]) and gain (1.26 [1.14-1.40]) were associated with stillbirth. Body mass index gain was positively associated with large-for-gestational-age infants and inversely associated with small-for-gestational-age infants.
Substantial interpregnancy body mass index changes were associated with modestly increased risk of severe maternal morbidity, stillbirth, and small- and large-for-gestational-age infants.
孕前体重指数和妊娠期体重增加与严重产妇发病率有关,这表明两次妊娠之间的体重变化也可能起作用,就像对新生儿结局的影响一样。
本研究评估了连续两次单胎妊娠之间孕前体重指数的变化与随后妊娠中严重产妇发病率、死产以及胎儿大小与胎龄不符的婴儿的关系。
本观察性研究基于加利福尼亚州连续 1,111,032 次妊娠的分娩记录,这些记录与医院出院记录相关联(2007-2017 年)。通过自我报告的体重和身高,从指数妊娠开始到随后妊娠开始计算两次妊娠之间的孕间体重指数变化。严重产妇发病率是根据疾病控制与预防中心的指数定义的,包括和不包括仅输血的病例。我们使用多变量对数二项式回归模型来估计调整后的风险,总体风险和根据指数出生时的孕前体重指数进行分层。
在未经调整的分析中,大量的孕间体重指数增加(≥4 kg/m)与严重产妇发病率相关,但在调整分析中则不然。大量的孕间体重指数减少(>2 kg/m)与严重产妇发病率增加相关(调整后的相对风险,1.13;95%置信区间(1.07-1.19)),大量减少(调整后的相对风险,1.11 [1.02-1.19])和增加(≥4 kg/m;调整后的相对风险,1.09 [1.02-1.17])与非输血性严重产妇发病率相关。大量减少(调整后的相对风险,1.17 [1.05-1.31])和增加(1.26 [1.14-1.40])与死产相关。体重指数增加与胎儿大于胎龄有关,与胎儿小于胎龄呈负相关。
大量的孕间体重指数变化与严重产妇发病率、死产以及胎儿大小与胎龄不符的婴儿的风险略有增加有关。